The year’s largest expo for Indiana startups — Innovation Showcase 2015 — is set for Thursday, July 9, at Speedway’s Dallara IndyCar Factory and has 74 companies lined up. At least a half-dozen have substantial ties to Indiana University, with five being products of the Spin Up program offered by the Indiana University Research and… Read more »
Tag: Technology Transfer
Translational research and entrepreneurship seminar set for July 14 at IUPUI to feature founder/director of Stanford's SPARK program
Dr. Daria Mochly-Rosen, who founded and directs Stanford University’s SPARK translational research and commercialization program, will discuss “Translational Research in Academia – Correcting Abnormal Mitochondrial Dynamics in Neurodegenerative Diseases” at a Tuesday, July 14, seminar at Indiana University Purdue University Indianapolis. The seminar is scheduled for 11 a.m. to noon in Room 1110 of the Health… Read more »
Week of June 14-20 will mark the inaugural celebration of Indiana Entrepreneurship Week
June 14-20 marks a statewide acknowledgement of Hoosier ingenuity known as Indiana Entrepreneurship Week. Established by the state’s Office of Small Business and Entrepreneurship, this event is the first of its kind in Indiana. It showcases top entrepreneurial talent, promotes entrepreneurship as a profession and educates small business owners on related issues. “The inaugural Entrepreneurship… Read more »
Innovate Indiana to appear at world's largest biotech event June 15-18 in Philadelphia
For the fourth year, the Indiana Health Industry Forum (IHIF) — a statewide association that represents members of Indiana’s health science community — will have a presence at the BIO International Convention, which is scheduled for June 15-18 in Philadelphia, Pa. The BIO International Convention touts itself as… Read more »
Indiana CTSI launches new initiatives, grows project development team with $5 million from Indiana Economic Development Corp.
Five million dollars awarded to the Indiana Clinical and Translational Sciences Institute (CTSI) by the Indiana Economic Development Corp. will be used to launch a molecular therapeutics program, a program that connects industry mentors to entrepreneur researchers and create an academic research commercialization hub for Indiana. Some of the money also will be used to… Read more »
IBRI announces new president and CEO, along with interim plans to lease office/lab space at IU Biotechnology Research & Training Center
A pair of notable news items have emerged concerning the Indiana Biosciences Research Institute (IBRI), a non-profit, industry-led effort whose stakeholders include key companies such as Biomet, Cook Medical, Dow AgroSciences, Eli Lilly & Co., Indiana University Health and Roche Diagnostics — along with the State of Indiana, BioCrossroads and university collaborators such as Indiana,… Read more »
California drug maker to evaluate IU-led research for potential cystic fiberosis therapy
Under an agreement with the Indiana University Research and Technology Corp., La Jolla Pharmaceutical Co. obtained an exclusive option to acquire intellectual property rights to “next-generation” offshoots of gentamicin. Gentamicin is part of a class of hospital-grade antibiotics known as aminoglycosides that are commonly used to treat staph, urinary tract, heart and pregnancy-related infections. Despite… Read more »
APLU advises member universities to review IP policy management, ensure transparency
As part of my duties as IU’s assistant vice president for federal relations, I have spent the past few months serving on a new task force formed by the Association of Public and Land-grant Universities. It focused on innovation, technology transfer and commercialization, with the specific purpose of examining various policies and values that universities… Read more »
Co-developers of Ebola drug ZMapp, IU-based treatment for PTSD among speakers at JCEB's first Innovation Conference at IU-Bloomington
The Johnson Center for Entrepreneurship in Biotechnology’s inaugural Innovation Conference at IU-Bloomington is scheduled for 12:30 p.m. to 6:30 p.m., April 24 in the Frangipani Room of the Indiana Memorial Union. It will feature speakers who cover topics related to commercializing academic research, including how to launch a business through IU’s Spin Up program. Additional topics… Read more »
IU-licensed drug for fragile X syndrome to be developed, marketed for Europe, Middle East
Indianapolis–based Confluence Pharmaceuticals Inc. and Vienna-based AOP Orphan Pharmaceuticals AG have reached an agreement to co-develop and market an Indiana University-licensed drug throughout Europe and the Middle East to combat the most commonly known genetic cause of autism. There are currently no approved treatments for the social and communicative impairments that accompany fragile X syndrome,… Read more »